COMPASS Pathways plc

NasdaqGS:CMPS 주식 보고서

시가총액: US$304.5m

COMPASS Pathways 관리

관리 기준 확인 4/4

COMPASS Pathways CEO는 Kabir Nath, Aug2022 에 임명되었습니다 의 임기는 2.25 년입니다. 총 연간 보상은 $ 2.82M, 21% 로 구성됩니다. 21% 급여 및 79% 보너스(회사 주식 및 옵션 포함). 는 $ 111.83K 가치에 해당하는 회사 주식의 0.037% 직접 소유합니다. 111.83K. 경영진과 이사회의 평균 재임 기간은 각각 2.3 년과 4.2 년입니다.

주요 정보

Kabir Nath

최고 경영자

US$2.8m

총 보상

CEO 급여 비율21.0%
CEO 임기2.3yrs
CEO 소유권0.04%
경영진 평균 재임 기간2.3yrs
이사회 평균 재임 기간4.2yrs

최근 관리 업데이트

Recent updates

Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity

Nov 01

Compass Pathways: Sector-Wide Reality Check Needed Post FDA Lykos MDMA Decision

Aug 19

Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies

Jul 08

Psychedelics Closer To Commercialization; Compass Far And Away The Leader

May 23

COMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way Or Slam The Door Shut?

Apr 25

Compass Pathways: Psilocybin Developer A Potentially Intriguing, Contrarian Play

Feb 08

Companies Like COMPASS Pathways (NASDAQ:CMPS) Are In A Position To Invest In Growth

Dec 06
Companies Like COMPASS Pathways (NASDAQ:CMPS) Are In A Position To Invest In Growth

Booker again pushes for easier access to psychedelics for terminally ill patients

Oct 19

Here's Why We're Not Too Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Situation

Aug 13
Here's Why We're Not Too Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Situation

COMPASS Pathways And The Trillion Dollar Opportunity

Aug 11

COMPASS Pathways ADS Q2 2022 Earnings Preview

Aug 03

COMPASS Pathways names new CEO

Jul 19

Compass Pathways: Shares Look Cheap But Proving Psilocybin Case Won't Be Easy

Jun 30

We're Hopeful That COMPASS Pathways (NASDAQ:CMPS) Will Use Its Cash Wisely

Apr 28
We're Hopeful That COMPASS Pathways (NASDAQ:CMPS) Will Use Its Cash Wisely

Checking In On Compass Pathways

Mar 02

We Think COMPASS Pathways (NASDAQ:CMPS) Can Afford To Drive Business Growth

Dec 29
We Think COMPASS Pathways (NASDAQ:CMPS) Can Afford To Drive Business Growth

Compass Pathways: Psychedelics For Mental Health

Nov 23

Compass Faces Tricky Road To Approval For Its Psychedelic Depressive Therapy

Sep 17

COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans

Sep 15
COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans

Compass Pathways: Huge Growth Potential, But I'm Cautious

Jun 04

COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans

May 25
COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans

COMPASS Pathways raises $144M capital via equity offering

Apr 30

COMPASS Pathways launches public offering

Apr 27

We're Not Very Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Rate

Feb 08
We're Not Very Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Rate

Psilocybin Will Change Mental Health, Compass Pathways Could Be At The Forefront

Jan 01

Compass Pathways: Risky And Overvalued

Dec 18

What Type Of Shareholders Make Up COMPASS Pathways plc's (NASDAQ:CMPS) Share Registry?

Dec 18
What Type Of Shareholders Make Up COMPASS Pathways plc's (NASDAQ:CMPS) Share Registry?

CEO 보상 분석

Kabir Nath 의 보수는 COMPASS Pathways 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-US$144m

Jun 30 2024n/an/a

-US$139m

Mar 31 2024n/an/a

-US$129m

Dec 31 2023US$3mUS$595k

-US$118m

Sep 30 2023n/an/a

-US$117m

Jun 30 2023n/an/a

-US$102m

Mar 31 2023n/an/a

-US$95m

Dec 31 2022US$8mUS$243k

-US$92m

보상 대 시장: Kabir 의 총 보상 ($USD 2.82M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 2.24M ).

보상과 수익: Kabir 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Kabir Nath (60 yo)

2.3yrs

테뉴어

US$2,824,758

보상

Mr. Kabir Kumar Nath M. A., M. B.A., is Chief Executive Officer and Director of COMPASS Pathways plc from August 1, 2022. He serves as President & CEO at Otsuka America Pharmaceutical, Inc. He served as Pr...

리더십 팀

이름위치테뉴어보상소유권
Kabir Nath
CEO & Director2.3yrsUS$2.82m0.037%
$ 111.8k
Matthew Owens
General Counsel & Chief Legal Officer2.8yrsUS$1.32m0.0059%
$ 18.0k
Guy Goodwin
Chief Medical Officer3.3yrsUS$1.20m0.0029%
$ 8.9k
Teri Loxam
CFO, Principal Financial Officer & Principal Accounting Officerless than a year데이터 없음데이터 없음
Greg Ryslik
Chief Technology Officer2.8yrs데이터 없음데이터 없음
Stephen Schultz
Senior Vice President of Investor Relationsno data데이터 없음데이터 없음
Christopher Williams
Chief Communications Officer2.1yrs데이터 없음데이터 없음
Anne Benedict
Chief People Officerno data데이터 없음데이터 없음
Lars Wilde
Senior Advisor2.8yrs데이터 없음데이터 없음
Susan Stansfield
Advisorno data데이터 없음데이터 없음
Michael Gold
Chief Research & Development Officerless than a year데이터 없음데이터 없음
Lori Englebert
Chief Commercial Officerless than a year데이터 없음데이터 없음

2.3yrs

평균 재임 기간

51yo

평균 연령

경험이 풍부한 관리: CMPS 의 관리팀은 경험 ( 2.3 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Kabir Nath
CEO & Director2.3yrsUS$2.82m0.037%
$ 111.8k
Alan Schatzberg
Member of Scientific Advisory Networkno data데이터 없음데이터 없음
Linda McGoldrick
Independent Non Executive Director4.2yrsUS$209.48k0%
$ 0
Gino Santini
Chairmanless than a year데이터 없음데이터 없음
David Norton
Independent Director6.5yrsUS$215.57k0.025%
$ 77.4k
Daphne Karydas
Independent Director1.2yrsUS$363.71k0%
$ 0
Robert McQuade
Independent Non Executive Director4.6yrsUS$210.84k0%
$ 0
Wayne Riley
Independent Non-Executive Director3.7yrsUS$200.86k0%
$ 0
Thomas Lonngren
Independent Non-Executive Director6.5yrsUS$199.82k0.13%
$ 396.3k
Annalisa Lisa Jenkins
Independent Non-Executive Director6.5yrsUS$214.78k0.051%
$ 155.2k
Diego Pizzagalli
Member of Scientific Advisory Networkno data데이터 없음데이터 없음
Gul Dolen
Member of Scientific Advisory Networkno data데이터 없음데이터 없음

4.2yrs

평균 재임 기간

67yo

평균 연령

경험이 풍부한 이사회: CMPS 의 이사회는 경험(평균 재직 기간 4.2 년)으로 간주됩니다.